Cell adhesion to extracellular matrix components such as
fibronectin has a complex basis, involving multiple determinants on the molecule that react with discrete cell surface macromolecules. Our previous results have demonstrated that normal and transformed cells adhere and spread on a 33-kD
heparin binding fragment that originates from the carboxy-terminal end of particular
isoforms (A-chains) of human
fibronectin. This fragment promotes
melanoma adhesion and spreading in an
arginyl-glycyl-aspartyl-serine (RGDS) independent manner, suggesting that cell adhesion to this region of
fibronectin is independent of the typical RGD/
integrin-mediated binding. Two synthetic
peptides from this region of
fibronectin were recently identified that bound [3H]
heparin in a solid-phase assay and promoted the adhesion and spreading of
melanoma cells (McCarthy, J. B., M. K. Chelberg, D. J. Mickelson, and L. T. Furcht. 1988. Biochemistry. 27:1380-1388). The current studies further define the cell adhesion and
heparin binding properties of one of these synthetic
peptides. This
peptide, termed
peptide I, has the sequence YEKPGSP-PREVVPRPRPGV and represents residues 1906-1924 of human plasma
fibronectin. In addition to promoting RGD-independent
melanoma adhesion and spreading in a concentration-dependent manner, this
peptide significantly inhibited cell adhesion to the 33-kD fragment or intact
fibronectin. Polyclonal
antibodies generated against
peptide I also significantly inhibited cell adhesion to the
peptide, to the 33-kD fragment, but had minimal effect on
melanoma adhesion to
fibronectin. Anti-
peptide I antibodies also partially inhibited [3H]
heparin binding to
fibronectin, suggesting that
peptide I represents a major
heparin binding domain on the intact molecule. The cell adhesion activity of another
peptide from the 33-kD fragment, termed CS1 (Humphries, M. J., A. Komoriya, S. K. Akiyama, K. Olden, and K. M. Yamada. 1987. J. Biol. Chem., 262:6886-6892) was contrasted with
peptide I. Whereas both
peptides promoted RGD-independent cell adhesion,
peptide CS1 failed to bind
heparin, and exogenous
peptide CS1 failed to inhibit
peptide I-mediated cell adhesion. The results demonstrate a role for distinct
heparin-dependent and -independent cell adhesion determinants on the 33-kD fragment, neither of which are related to the RGD-dependent
integrin interaction with
fibronectin.